Recommended by Medical and Care Providers
TempShield™ supports early detection of acute cancer-related complications, including infection, UTI, thrombosis, and sepsis, as part of a proactive patient care plan.
TempShield™ enables continuous, real-time core temperature tracking - critical for detecting infections before symptoms emerge.
TempShield Powers New Standard of Care for Cancer Patients
✓ Continuous body temperature monitoring
✓ 90 day battery
✓ Comfortable design
✓ FDA cleared
✓ Text messages and calls from monitoring team when your temperature triggers an alert
✓ Caregiver connectivity – enables your loved ones to see if you have a fever.
TempShield™ Delivers Early Infection Detection When It Matters Most¹
Infections can escalate rapidly - early temperature trend detection allows clinicians to intervene sooner and potentially avoid hospitalizations.
Up to 92%
reduction in mortality in at-risk populations
79%
decrease in hospitalization days
98%
Recommended
✓ Fever is one of the earliest clinical signals of acute cancer events.
✓ Approximately 40% of cancer patients experience an unplanned hospitalization following diagnosis in the first year.²
✓ Nearly 60% of deaths in high-risk cancer patients is driven by infection.³
What Physicians & Patients Are Saying
“The TempShield is to cancer patients like the glucose monitor is to diabetics. We have seen that the TempShield is the difference between an antibiotic and hospitalization.”
Dr. Tallat Mahmood
MEDICAL DIRECTOR AT ROSWELL PARK CANCER,
ELLIS MEDICINE
“TempShield gives me peace of mind by alerting me when my temperature changes, allowing my care team to act proactively. It has been an excellent experience, and I would recommend it to all cancer patients.”
Maureen Caba
BREAST CANCER PATIENT
“It’s been very comforting having this device on him...to know that if something happens, somebody’s got our back”
Linda
MOTHER OF ADRENOCORTICAL CANCER PATIENT
Privacy Policy, Terms and Conditions, and Copyright © 2026 AION Biosystems™, Inc.
175 Cabot Street, Suite 100, Lowell, MA 01854, United States
All content on this website, including but not limited to text, graphics, logos, icons, images, and videos, are the exclusive property of AION Biosystems™. Any unauthorized use or reproduction or modification of these materials is prohibited.
1. Mahmood, T., Currier, E., Arogosa, A., Pabba, M., Keleki, Z. G., Li, G., & Montalto, N. (2025). Long-term continuous temperature monitoring at a community cancer center: Towards a new standard of care in oncology. Journal of Clinical Oncology, 43(16_suppl), e13883. https://doi.org/10.1200/JCO.2025.43.16_suppl.e13883
2. Whitney, R. L., Bell, J. F., Tancredi, D. J., Romano, P. S., Bold, R. J., Wun, T., & Joseph, J. G. (2019). Unplanned hospitalization among individuals with cancer in the year after diagnosis. Journal of Oncology Practice, 15(1), E20–E29. doi: 10.1200/JOP.18.00254.
3. Zheng, Y., Chen, Y., Yu, K., Yang, Y., Wang, X., Yang, X., Qian, J., Liu, Z.-X., & Wu, B. (2021). Fatal infections among cancer patients: A population-based study in the United States. Infectious Diseases and Therapy, 10(2), 871–895. https://doi.org/10.1007/s40121-021-00433-7 PMC